Home > Insider Trading > Filing (0001415889-16-005891)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1591165	Medovex Corp.	MDVX	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1629409	S Jarrett Gorlin	3279 Hardee Avenue Atlanta GA 30341	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-04-19	43,028	$1.26	560,065	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to purchase shares of Common Stock	Acquisiton	2016-04-19	21,514	$0.00	21,514	$1.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
62,314	2016-10-19	2021-04-19	No	4	P	Direct

Footnotes

On April 21, 2016, the Reporting Person filed a Form 4 with the Commission. The previously filed Form 4 reported the purchase of shares of common stock (the "Shares") of MedoveX Corporation (the "Company"). In compliance with NASDAQ rules and regulations, the Reporting Person is hereby amending his report to accurately reflect the correct number of Shares purchased which was reduced, effectively increasing the purchase price from $1.225 to $1.255.
Represents shares held by The Jarrett S. & Rebecca L. Gorlin Family Limited Partnership. Mr. Gorlin disclaims beneficial ownership of these shares.
The Warrant is initially exercisable six months following the date of issuance (04/19/2016) for a period of five (5) years from the date of issuance
On April 21, 2016, the Reporting Person filed a Form 4 with the Commission. The previously filed Form 4 reported the purchase of a warrant to purchase shares of common stock (the "Warrant") of MedoveX Corporation (the "Company"). In compliance with NASDAQ rules and regulations, the Reporting Person is hereby amending his report to accurately reflect the correct number of underlying shares that the Warrant represents, which was reduced pursuant to NASDAQ guidelines.